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Cutaneous wound-healing disorders are a major health problem that requires the development of innovative
treatments. Whithin this context, the search for reliable human wound-healing models that allow us to address both
mechanistic and therapeutic matters is warranted. In this study, we have developed a novel in vivo wound-healing
model in a genetically modiﬁed human context. Our model is based on the regeneration of human skin on the back
of nude mice by transplantation of a cultured bioengineered skin equivalent previously designed in our laboratory.
In this setting, human keratinocytes in the epidermal compartment were genetically modiﬁed with a retroviral
vector encoding the enhanced green ﬂuorescent protein (EGFP). After stable engraftment of the EGFP skin was
achieved (9–12 wk after grafting), a small circular full thickness wound was performed on this mature human skin. A
wide variety of parameters involved in wound healing were monitored, including tissue architecture, cell prolif-
eration, epidermal differentiation, dermal remodelling, and basement membrane regeneration. Wounded gene-
targeted skin-humanized mice re-capitulated native skin wound-healing features. In addition, when keratinocyte
growth factor (KGF), a growth factor that has been shown to improve wound healing, was added to wounds during
3 d, the re-epithelialization was significantly accelerated. The present wound-healing model system provides a
suitable in vivo tool to test gene transfer strategies for human skin repair. It also serves as a complementary
platform for studies in genetically modiﬁed mice and as a model to evaluate pharmaceutical therapeutic ap-
proaches for impaired wound healing.
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Cutaneous injury represents a potential risk for the integrity of
the organism. Wound healing is a dynamic, interactive and
complex process that involves soluble factors, extracellular
matrix, and epidermal and mesenchymal cells undergoing
cell proliferation, migration, and differentiation events (Berei-
ter-Hahn, 1986; Clark, 1996; Martin, 1997; Singer and Clark,
1999). Keratinocytes that reconstituted an organized, strat-
ified and squamous epithelium accomplish the re-epithelia-
lization or permanent covering of the defect. To ensure
successful repair, fibroblasts also play an important role. In-
itially, fibroblasts migrate into the wound space, proliferate,
and begin to fill the defect by synthesizing new extracellular
matrix components such as fibronectin. Later on, during the
remodelling phase, fibroblasts produce and deposit collagen
in the dermal matrix. The regeneration of a functional skin
also depends on the reconstitution of the dermo-epidermal
junction, which anchors the epidermis to the dermis. Despite
all the knowledge accumulated to date, there is no effective
treatment for most healing impairments. The skin as a de-
livery system for therapeutic proteins has recently been
proved to be a feasible approach (Larcher et al, 2001; Spirito
et al, 2001). The use of skin substitutes acting concomitantly
as a covering and as a source of soluble factors to improve
the healing of wounds is currently under study at various
laboratories including ours (Eming et al, 1998; Del Rio et al,
1999; Andreadis et al, 2001; Supp and Boyce, 2002).
To date, the thickness and opacity of the dermis com-
bined with the difficulty of processing wounds with scabs
have hampered studies of mammalian wound healing.
Hence, the mechanisms of skin wound repair, especially in
human beings, have long been debated but still remain un-
clear. Furthermore, ethical considerations have naturally
limited research. Only few studies have assessed wound
healing in vivo using native skin from human volunteers
(Odland and Ross, 1968; Ross and Odland, 1968; Ortonne
et al, 1981; Mansbridge and Knapp, 1987; Cavani et al,
1993; Paladini et al, 1996). Thus, current knowledge of the
issue mainly stems from the use of animal models such as
the canine (Winstanley, 1975a, b), and murine (Croft and
Tarin, 1970; Tarin and Croft, 1970; Krawczyk, 1971) models
and the use of knockout mouse and transgenic strategies
thus proving the relevance of targeted genes (Scheid et al,
2000; Werner and Grose, 2003). Moreover, the use of animal
models that have some form of delayed wound healing,
such as genetically diabetic mice, has provided evidence of
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the modulatory effects of many growth factors in vivo
(Werner et al, 1994). In vitro systems such as conventional
two-dimensional (Biddle and Spandau, 1996) cultures or
three-dimensional human skin equivalents (Garlick and
Taichman, 1994; Andreadis et al, 2001; Laplante et al,
2001; Falanga et al, 2002) have also contributed to the
knowledge of the healing process. For most of the studies,
however, the question remains as to how far the results can
be extrapolated to the human in vivo situation. Within this
context, the need for the development of human wound
healing models in an in vivo environment arises.
Herein we describe a novel wound healing model based
on the injury of genetically modified human skin regenerated
on mice after stable engraftment of a skin equivalent previ-
ously designed in our laboratory (Meana et al, 1998; Del Rio
et al, 2002; Serrano et al, 2003) and currently used in clinical
practice for permanent skin regeneration (Llames et al, 2004).
The grafting of genetically modified skin equivalents to
big size full thickness wounds on immunodeficient mice has
been previously performed to study the effects of the trans-
ferred genes on early graft performance. In fact these stud-
ies usually focus on a time frame that coincides with acute
graft take (7–15 d post-grafting) (Eming et al, 1995, 1998;
Del Rio et al, 1999; Supp et al, 2000a, b; Hamoen and
Morgan, 2002; Supp and Boyce, 2002). In the present study,
however, we have not analyzed the skin regeneration proc-
ess immediately after grafting. Instead, the excisional stud-
ies were performed 9–12 wk after grafting. This length of
time allows for both epidermal morphology maturation and
dermal matrix remodelling. Thus, the skin equivalent un-
dergoes two process of skin repair: (1) immediately after
grafting to full-thickness wounds (12 mm circular wounds)
on immunodeficient mice, to regenerate a human skin
in vivo and (2) After stable engraftment was achieved to
accomplish wound closure of a small full-thickness wound
(2 mm circular wound) performed, on mature and geneti-
cally modified human skin. During the healing of these small
full-thickness wounds a wide spectrum of parameters, at
different times post-wounding, were studied including mi-
gration, proliferation, stratification, and differentiation of
enhanced green fluorescent protein (EGFP)-modified kera-
tinocytes, fibroblast migration, dermal remodelling, and
dermo-epidermal junction reconstitution.
The biological validity of the model was further confirmed
using recombinant KGF added exogenously to the wounds.
Our wound-healing model using genetically modified
keratinocytes appears a reliable platform to test gene-
based wound-healing therapies.
Results
Phenotypic characterization of unwounded human skin in
the skin-humanized mice Grafting of the fibrin-based skin
construct regenerates in mice an EGFP-genetically modified
human skin that closely resembles native human skin phe-
notype. The size and the permanence of the regenerated hu-
man skin allows for the induction of excisional full-thickness
wounds. Details of the procedure are shown in Fig S1.
Although they can be easily distinguished by hem-
atoxylin–eosin staining, the human and the murine skin
were unequivocally identified by the expression of specific
human markers and EGFP immunostaining (Fig S2a, b, and
d). EGFP-modified human skin showed a well-differentiated
and stratified epidermis with suprabasal layers immuno-
positive for human involucrin, denoting a normal develop-
ment of the differentiation program (Fig S2a). Persistence
of human dermal fibroblasts in the mature dermal area of
the regenerated skin was evidenced by human vimentin ex-
pression (Fig S2b). Both human involucrin and vimentin
staining depict the boundaries between mouse and human
tissues.
In the unwounded skin, the epidermis overlay a mature
collagenous matrix as revealed by Masson’s trichrome
staining (Fig S2c). The collagenous murine and human de-
rmis appear as a continuous matrix with indistinguishable
boundaries.
It is noteworthy that persistent EGFP expression in stable
engrafted skin (Fig S2d ) exerted a neutral effect on the
physiology of transgenic human skin when compared with
control (untransduced).
Wound healing in skin-humanized mice The re-epithe-
lialization process after wounding was monitored by anal-
yzing data from the full extension of the wound. A com-
parative histological (H&E) analysis of the center of the
wound on different days post-wounding was performed.
Figure 3 shows how both the neoepidermis and the ne-
odermis progressed toward the wound center after injury.
By 1 d post-wounding the wound margins (Fig 1a) were
easily recognizable by an abrupt interruption in the epithelial
(arrows) and dermal continuity. A scab covered the wound
in close contact with the provisional matrix (asterisk).
At 3 d post-wounding a migratory tongue of epidermal
cells (outlined by a dashed line) penetrated into the wound
bed (Fig 1b) under the scab. The forward part of the tongue
(tongue tip) was composed of a monolayer, progressively
followed by a bilayer and a disorganized, multilayered ep-
ithelium toward the wound margins (tongue tail).
At 7 d post-wounding, the center of the wound was fully
covered by a stratified neoepithelium (Fig 1c; outlined by a
dashed line). An immature neodermis (asterisk) underlay the
neoepithelium. A similar picture was observed at 15 d post-
wounding, although the neoepidermis lay on a more mature
dermal bed (see Fig S4b vs c).
Species origin of the components involved in wound re-
pair The keratinocytes that re-epithelialized the wound ex-
pressed the EGFP protein, in all the different layers, as
demonstrated 3 and 7 d post-wounding (completed cover-
age) (Fig S3a and b).
The use of specie specific antibodies (human involucrin
and vimentin antisera) allowed us to confirm that the cells
involved in the re-epithelialization and repopulation of the
dermis after small excisional wounding were of human origin.
After 3 and 15 d, the wound bed was partially or com-
pletely invaded by keratinocytes that were immunopositive
for human involucrin in the suprabasal layers (Fig S3c and d,
respectively).
At 3 d post-wounding, no fibroblasts positive for human
vimentin were present in the center of the wound bed. It is
noteworthy that at this early time point of wound healing,
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dermal fibroblasts that were immunopositive for human
vimentin, had just started dermal tissue remodelling (i.e., mi-
gration) and appeared far behind the epithelial tongue (Fig
S3e). At 7 d post-wounding the wound bed was further pop-
ulated by human vimentin immunopositive cells (Fig S3f).
Cytoskeletal plasticity changes during wound repair The
phenotypic changes of the epithelial migratory tongue were
investigated in detail using several cytoskeleton markers.
We have mainly focused on the changes occurring at 3 d
post-wounding, a time point when wound closure is actively
progressing (Fig 2).
One of the most prominent phenomena is the rearrange-
ment of the intermediate filament cytoskeleton. Thus, kera-
tins showed changes of expression toward the leading edge
of the tongue. The expression of the suprabasal keratin K10
(Fig 2a, inset) progressively disappeared in the leading edge
(Fig 2a) and the basal cell-specific keratin K5 (Fig 2d, inset)
is also expressed in suprabasal keratinocytes (Fig 2c and d).
Keratin K16 expression, a marker of keratinocyte hyperpro-
liferation, which is highly induced at the wound margins
gradually faded in the leading edge (Fig 2b). Remarkably,
concomitant with the change in keratin markers, a robust
vimentin expression in the keratinocytes of the epithelial
tongue tip occurred (Fig 2c and e). Immunoperoxidase
staining revealed, at high magnification, that some vimen-
tin-positive keratinocytes with migratory phenotype ap-
peared to roll-over other vimentin-positive keratinocytes
along the tip of the tongue (Fig 2f and g).
Associated with the changes in keratin 5 and vimentin we
have observed that the epithelial migratory tongue showed
a marked decreased in E-cadherin immnunostaining toward
the tongue tip (data not shown).
Dermal matrix regeneration The kinetics of connective
tissue regeneration was studied employing Masson’s tri-
chrome staining (Fig S4). The composition of the dermal
matrix underwent changes from an original fibrin clot (1 d
post-wounding) to a granulation tissue (3–7 d post-wound-
ing) and a collagenous dermis (15 d post-wounding). At 1 d
after injury, the wound was plugged by a provisional matrix
containing blood vessels and invading cells consistent with
inflammatory elements (Fig S4a and d ). At 3 d post-wound-
ing, a well-developed granulation tissue was established
(data not shown). At 7 d after injury, the granulation tissue
was rich in cells and still poor in collagen bundles as shown
Figure 1
Re-epithelialization of wounds in skin-
humanized mice. (a) Microphotograph
taken at 1 d post-wounding. Wound mar-
gins indicated by arrows. (b) Microphoto-
graph of a migratory epidermal tongue
penetrating the wound bed (3 d post-
wounding). (c) Microphotograph showing
a re-epithelialized wound at 7 d post-
wounding. In all panels, dermo-epidermal
boundaries are outlined by dashed lines.
Asterisks are placed on the temporary
dermal matrix of the wound bed.
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by Masson’s trichrome light and diffuse blue staining (Fig
S4b and e). At 15 d post-wounding, the density and labelling
intensity of the collagen bundles increased whereas the
number of cells decreased (Fig S4c). At this time the matrix
still exhibited linear collagen bundles (Fig S4f ). In contrast,
in flanking areas of the wound, the connective tissue
showed a higher intensity of Masson’s trichrome staining
(Fig S4g) and the collagen bundles acquired an ‘‘angel curl-
shaped structure’’ typical of mature human skin.
Dermo-epidermal junction regeneration (DEJ) As in na-
tive human skin, in the stable engrafted human skin hu-
man laminin was localized at the dermo-epidermal junction
(Fig S5a).
As a result of the excisional wound through the entire
thickness of the skin the basement membrane was
removed. To assess for the reformation of basement mem-
brane after wounding, expressions of two major com-
ponents, i.e., type IV collagen and human laminin were
monitored by immunostaining, using specific monoclonal
antibodies. At 3 d after wounding, type IV collagen was
absent at the distal tip of the migratory epidermal tongue
(Fig S5b, outlined by a dashed line). Collagen type IV, how-
ever, became detectable underneath the newly stationary
epidermis of the wound margin (Fig S5b, arrowhead). By 7
d, discontinuous labelling for laminin was observable in re-
gions close to the wound center that was covered by a
disorganized neoepithelium (Fig S5c, arrows). At 15 d
post-wounding both collagen IV and laminin were present
at the center of the wound (Fig S5d and data not shown,
respectively).
Restoration of the differentiation program after wound-
ing To assess for the restoration of the late differentiation
program, we studied the expression of loricrin, a marker of
keratinocyte terminal differentiation. In the unwounded ar-
eas of the regenerated EGFP human skin, as in native hu-
man skin, expression of loricrin by keratinocytes was
confined to the cornified and granular layers (Fig 3). By 1 d
post-wounding (Fig 3a and b) a lack of loricrin expression
was observed in the disorganized margin of the wound
whereas in unwounded areas the expression was con-
served. At 3 d post-wounding, the epithelial migrating
tongue (Fig 3c and d ) was negative for loricrin. In both
cases, the unlabelled keratinocytes had an undifferentiated
phenotype. Further from the tip of the tongue, toward the
unwounded area, the expression of loricrin became pro-
gressively closer to normal. Seven days post-wounding
(Fig 3e and f ) a faint and discontinuous expression of
loricrin was already present in the center of the wound. At
15 d post-wounding (Fig 3g and h) the expression of loricrin
by the whole neoepithelium that covered the wound was
completely restored.
Proliferative activity in response to wound Restoration of
normal skin architecture during wound healing results from
both migration and mitosis. The kinetics of proliferative ac-
tivity was monitored by evaluating bromodeoxyuridine (BrdU)
Figure 2
Cytoskeletal plasticity during wound repair in en-
hanced green fluorescent protein (EGFP)-bioengi-
neered skin-humanized mice (3 d post-wounding).
From panels a to e dermo-epidermal boundaries are out-
lined by dashed lines. (a) Immunoperoxidase staining of
keratin K10 in a migratory epidermal tongue. Inset: nor-
mal pattern of keratin K10 expression in unwounded skin-
humanized mouse. (b) Immunoperoxidase staining of
keratin K16 in a migratory epidermal tongue. (c) DAPI
nuclear staining of the migratory epidermal tongue shown
in d and e. (d) Immunofluorescence staining of keratin K5
in the same section shown in panel c. Inset: normal pat-
tern of keratin K5 expression in unwounded skin-human-
ized mouse. (e) Immunofluorescence staining of vimentin
in the same section shown in panel c. Inset: normal pat-
tern of vimentin expression in unwounded skin-human-
ized mouse. (f). Vimentin immunoperoxidase staining of a
migratory epidermal tongue. (g). Close-up view of the
marked area, black rectangle, in panel f.
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incorporation in both the unwounded regenerated EGFP-hu-
man skin and at 1, 3, 7, and 15 d post-wounding (Fig S6). In
unwounded regenerated EGFP-human skin cell proliferation
occurred in epidermal and dermal compartments. Both ker-
atinocytes and fibroblasts incorporated BrdU into the nuclei
(Fig S6a, arrows). Labelling was restricted to a basal location
in the epidermis. It is noteworthy that persistent EGFP ex-
pression in stable engrafted skin exerted a neutral effect on
the BrdU labelling index of transgenic human skin when
compared with untransduced control (3.5%  0.6% vs
3.0%  2.7% of basal keratinocytes; Fig S6d ). A transient
burst of proliferative activity occurred 1–3 d after wounding
(24.5%  0.4% and 28.4%  16.4% of the basal epidermal
cells, respectively; Fig S6b and d). Note that at 1 d post-
wounding, the proliferative cells are accumulated in the tail of
the tongue whereas at 3 d the accumulation tends to occur in
the middle zone (Fig S6e). No keratinocyte incorporating
BrdU, however, was observed at the tip of the migratory
tongue (Fig S6b and e). At 7 d, the center of the wound still
showed a marked proliferating activity that sometimes also
involved suprabasal keratinocytes (13.1%  3.6%; Fig S6d ).
At 15 d after wounding, the proliferative activity remained
increased in the neoepithelium (9.4%  1.3%; Fig S6d ) when
compared with unwounded areas.
rKGF improves wound healing in the skin-humanized
mouse model To determine the ability of the regenerated
skin to respond to stimulatory agents, exogenous recom-
binant KGF was applied on healing wounds. The effect of
KGF on the healing of 2 mm wounds was evaluated at 3 d
post-wounding (third day after the beginning of treatment).
Four criteria, namely, re-epithelialization, epidermal thick-
ness, basal cell density, and proliferation index were used
to quantify the effects of rKGF on the healing of stable en-
grafted human skin (Fig 4 and Table S1).
The percentage of re-epithelialization increased in KGF-
injected wounds (Fig 4a vs b and Table S1). In addition,
rKGF injection induced significant epidermal thickening
(Fig 4c vs d and Table S1). Moreover, the evaluation of the
number of basal cells per unit length of basement mem-
brane showed that the density of basal keratinocytes was
significantly higher in the rKGF-injected wounds (Fig 4a vs b
and Table S1), and the cells were tightly packed and elon-
gated. Finally, the proliferative response was significant-
ly increased in KGF-injected wounds (1.5-fold increase,
po0.05; Fig 4e vs f ). In keeping with previous findings for 3
d after wounding, the burst of proliferative activity occurred
in the middle of the migratory tongue and no keratinocyte
incorporating BrdU was observed at the tip of the migratory
tongue (Fig 4e and f ).
Discussion
Previous wound-healing studies using genetically modified
human skin grafted on mice have been focused on early
Figure 3
Restoration of the differentiation pro-
gram during wound repair in enhanced
green fluorescent protein (EGFP)-bio-
engineered skin-humanized mice. Im-
munoperoxidase staining of loricrin. (a)
Composite picture showing a panoramic
view of a 1 d wound. (b) Higher magnifi-
cation microphotograph taken from the
right wound margin shown in panel a
(rectangle). (c) Composite picture showing
a panoramic view of a 3-d wound. Note
the negative epithelium at the tip. (d)
Higher magnification microphotograph
taken from the middle zone of the right
tongue shown in panel c (rectangle). (e).
Composite picture showing a panoramic
view of a 7-d wound. (f) Higher magnifi-
cation microphotograph taken from the
center of the wound shown in panel e
(rectangle). Note loricrin was mostly ex-
pressed in the cytoplasm. (g) Composite
picture showing a panoramic view at 15 d
post-wounding. (h) Higher magnification
microphotograph taken from the center of
the wound shown in panel g (rectangle).
Note restoration of the normal membra-
nous pattern of loricrin expression in
granular cells.
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time point analysis of graft behavior. The central aim of such
studies was to examine the transient improvement of the
graft take process. Thus, within 7–15 d post-grafting (a time
frame that coincides with acute healing of the graft), the
effects of the transferred genes were tested on the accel-
eration of graft invasion by fibrovascular cells and the dep-
osition of collagen (Eming et al, 1995; Eming et al, 1998,
PDGF-modified grafts), on graft vascularization (Del Rio
et al, 1999; Supp et al, 2000a, b; Supp and Boyce, 2002,
VEGF-modified grafts) and on epidermal proliferation (Ham-
oen and Morgan, 2002, HGF-modified grafts). In contrast,
the aim of our study was not to test short-term effects on
grafting but rather to assess the wound-healing process of a
small full-thickness wound in a mature, ‘‘quiescent’’ regen-
erated human skin that permanently expresses a transgene.
Therefore, while previous studies refer to animal models
that mimic the healing of a big-size wound that requires
graft transplantation to achieve skin repair, such as grafting
of a burn victim with a skin substitute, our model mimics
small excisional wounds in volunteers.
One critical issue in our model is the persistence of
transgene expression in the skin in vivo. To the best of
our knowledge, there is no other model system that allows
for wound-healing studies in permanently modified human
skin. Permanent gene expression occurs in our pre-clinical
system through epidermal stem-cell targeting, as shown in
two previous studies by our group (Del Rio et al, 2002; Ser-
rano et al, 2003). In keeping with these findings, in the
present study, stable EGFP expression is consistent with
targeting of the epidermal stem cell compartment since the
length of expression spans multiple epidermal turnover cy-
cles for regenerated human skin (3–4 wk duration per cycle;
Robbins et al, 2001). Experimental evidence indicates that
fibrin, the material used as a dermal scaffold in our cultured
skin equivalent, greatly perform to maintain the stem cell
population in vivo (Del Rio et al, 2002; Serrano et al, 2003).
Permanent epidermal regeneration has been shown in clin-
ical practice when fibrin-based skin equivalents were graft-
ed to severe burn patients, providing unequivocal evidence
of functional stem cell persistence also in humans (Pellegrini
et al, 1999; Ronfard et al, 2000; Llames et al, 2004). Herein,
we showed that persistent EGFP gene expression in the
keratinocytes exerts a neutral effect on the physiology of
the wound-healing process, allowing for wound healing
studies in gene-transferred human skin after stable en-
graftment. Previously, in vitro studies of wound healing us-
ing human keratinocytes genetically marked with retroviral
vectors have shown that targeted cells respond similarly
to non-transduced cells (Garlick et al, 1991; Garlick and
Taichman, 1994).
Earlier studies in human subjects and in a diversity of
animals (Odland and Ross, 1968; Croft and Tarin, 1970;
Krawczyk, 1971; Winstanley, 1975a, b; Ortonne et al, 1981;
Mansbridge and Knapp, 1987; Cavani et al, 1993) showed
that the healing of a cutaneous wound proceeds according
to the following sequence of overlapping events: inflamma-
tion, production of granulation tissue, re-epithelialization
(reconstruction of a DEJ), and remodelling of that tissue to
form a neodermis (Clark, 1996).
In the present study we provide in vivo evidence that the
genetically modified skin-humanized mouse model recapit-
ulates the main features of native human wound healing,
which we have carefully dissected using both epithelial and
stromal markers.
Intermediate filament cytoskeleton plasticity appears as
one of the hallmarks of the re-epithelialization event. Thus,
K5 and K10, members of the major keratin pairs in the ep-
idermis (Fuchs, 1990), showed changes in their expression
toward the wound tongue tip. Therefore, in the tongue tip
K5 appears to be expressed in keratinocytes in various
Figure 4
rKGF improves wound healing in the skin-humanized mouse model. (a) Composite picture showing the center of a PBS-injected 3-d wound
stained with H&E. (b) Composite picture showing the center of a KGF-injected 3-d wound stained with H&E. Note that rKGF protein reduces the
epidermal gap distance. (c) Higher magnification of a PBS-injected skin-humanized mice. (d) Higher magnification of a KGF-injected skin-humanized
mice. Note that rKGF protein increases epidermal thickness and basal cell density. (e) Immunoperoxidase bromodeoxyuridine (BrdU) staining of a
PBS-injected 3-d wound. (f). Immunoperoxidase BrdU staining of a KGF-treated 3-d wound. Note that rKGF protein increases the number of BrdU-
positive nuclei.
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epidermal layers (including suprabasal layers) whereas
expression of K10 gradually fades toward the tip. Concom-
itantly, expression of vimentin in basal keratinocytes occurs,
indicating an epithelial–mesenchymal transition, a phenom-
enon that correlates with the acquisition of an active cell
migratory phenotype (Steinert and Roop, 1988; Gibbins
et al, 1999; Gilles et al, 1999; Boyer et al, 2000; Kiemer et al,
2001). The transient focal co-expression of vimentin and
cytokeratins by leading keratinocytes of the migratory
tongue during epithelial wound healing has been previous-
ly reported in in vitro and ex vivo studies (SundarRaj et al,
1992; Biddle and Spandau, 1996; Buisson et al, 1996).
As predicted, in wounded transgenic human skin, K16
expression was induced after injury and was located in
suprabasal keratinocytes at the wound edge, behind the
migratory keratinocytes of the epidermal tongue, an area
that presents a high BrdU labelling index. This result is
consistent with previous data demonstrating K16 induction
associated to hyperproliferation (Weiss et al, 1984; Leigh
et al, 1995) and involved in enabling the differentiating ker-
atinocyte to become competent for re-epithelialization
(Mansbridge and Knapp, 1987; Paladini et al, 1996).
As the migratory epithelial tongue advanced from the
surrounding margins, the expression of differentiation mark-
ers K10, and loricrin reproduced the centripetally progres-
sive differentiation that occurs during re-epithelialization
(Odland and Ross, 1968; Ortonne et al, 1981; Demarchez
et al, 1986; Garlick and Taichman, 1994; Laplante et al,
2001). In keeping with other studies on human wound heal-
ing, genetically modified human skin re-epithelialization was
completed 7 d post-wounding (Demarchez et al, 1986; Ca-
vani et al, 1993). In the same way, the normal differentiation
pattern, involving involucrin, K10 and loricrin, was restored
in the transgenic skin-humanized mice 15 d after wounding
(Odland and Ross, 1968; Ortonne et al, 1981; Demarchez
et al, 1986; Garlick and Taichman, 1994; Laplante et al,
2001).
During wound healing of gene-targeted skin-humanized
mice, the re-epithelialization of the wound occurs by mi-
gration of human keratinocytes in contact with a chimearic
human/mouse granulation tissue. We found that the se-
quence of events involving type IV collagen and laminin
restoration is very similar to that described for wound heal-
ing in human volunteers (Odland and Ross, 1968; Ross and
Odland, 1968; Larjava et al, 1993; Paladini et al, 1996;
Burgeson and Christiano, 1997).
During the early stages corresponding to the epidermal
and basement membrane reconstruction phase, the gran-
ulation tissue (mostly of mouse origin) was rich in cells em-
bedded in a loose matrix that was poor in collagen and
highly vascularized. At 3 d post-wounding a migratory
tongue of human fibroblasts started to invade the wound
bed of the transgenic skin. Interestingly, Demarchez and
collaborators working with wounds performed in unmodi-
fied human skin biopsies grafted onto nude mice showed
that when human fibroblasts were present in the dermis of
the graft, migration of host fibroblasts was avoided (De-
marchez et al, 1987; Rossio-Pasquier et al, 1999). Although
the issue was not addressed in this study, it is very likely
that collagen deposited in regions undergoing wound repair
was of human origin.
As previously described in other in vitro and in vivo
wound-healing models (Matoltsy and Viziam, 1970; Wins-
tanley, 1975b; Garlick and Taichman, 1994; Laplante et al,
2001; Falanga et al, 2002), a burst of proliferative activity
during re-epithelialization occurred in the skin-humanized
mice. The burst occurred 1–3 d after wounding, during the
process of covering of the wound floor. An elevated prolif-
erative activity persisted around 7 d post-wounding, at the
time that the epithelium covering the wound floor undergoes
stratification. At this time labelled nuclei are also found in
suprabasal layers revealing a faster turnover of the newly
formed epithelium and a shorter time for cells to differen-
tiate. These phenomena result in a thickened and hyper-
plastic neoepithelium as previously reported in animal
models (Croft and Tarin, 1970; Krawczyk, 1971; Winstanley,
1975a, b) and in human volunteers (Odland and Ross,
1968). Furthermore, our results support previous studies
demonstrating a delayed and transient increase in prolifer-
ative activity at the wound margin beginning after migration
has initiated (Winstanley, 1975b; Garlick and Taichman,
1994; Laplante et al, 2001).
Using this model, we have been able to capture certain
images such as those of cells ‘‘rolling over one another’’, an
observation consistent with the ‘‘frog leap’’ model proposed
by Krawczyk (1971) and still debated (Garlick and Taich-
man, 1994; Paladini et al, 1996; Laplante et al, 2001).
Finally, our system is able to respond to rKGF added
exogenously to wounds (Werner, 1998; Werner and Grose,
2003). As shown in another model (Staiano-Coico et al,
1993; Pierce et al, 1994; Werner, 1998; Andreadis et al,
2001), wounds performed in skin-humanized mice and treat-
ed with rKGF displayed an increase in epidermal thickness
and proliferation that resulted in accelerated wound closure.
In conclusion, the gene-targeted skin-humanized mouse
model would be useful to identify relevant genes involved in
cutaneous repair, providing a complementary or alternative
tool to transgenic mouse skin wound healing.
Materials and Methods
Primary cultures of human keratinocytes and ﬁbroblasts Hu-
man keratinocytes and dermal fibroblasts were obtained from skin
biopsies of donors by enzymatic digestion (Rheinwald and Green,
1975). Primary keratinocytes were cultured on a feeder layer of
lethally irradiated (X-ray; 50 Gy) 3T3-J2 cells (a gift from Dr J. Gar-
lick, SUNY) as previously described (Meana et al, 1998; Del Rio
et al, 2002). The keratinocyte seeding media was a 3:1 mixture of
Dulbecco’s Modified Eagle Medium (DMEM) (GIBCO-BRL, Barce-
lona, Spain) and HAM’S F12 (GIBCO-BRL) containing 10% fetal
calf serum (FCS), 0.1 nM choleric toxin, 2 nM T3, 5 mg per mL
insulin, and 0.4 mg per mL hydrocortisone. Primary fibroblasts were
cultured on plastic in DMEM containing 10% FCS. Cells were
cultured at 371C in a humid atmosphere containing 5% CO2. The
culture medium was changed every 2 d.
Gene transfer to primary keratinocytes The packaging cell line
PA317 (ATCC) was used to generate a stable cell line to produce
amphotropic retroviral particles containing the pLZR-ires-EGFP
sequence. Primary human keratinocytes were genetically modified
by retroviral gene transfer according to Del Rio et al (2002). Ker-
atinocytes were analyzed for EGFP expression and selected by
fluorescence-activated cell sorting (FACS) on a FACStar PLUS flow
cytometer (Becton Dickinson, San Jose, California).
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Wound-healing experimental design in skin–humanized mi-
ce The in vivo wound-healing model was designed by wounding a
stable engrafted human skin on nude mice (9–12 wk post grafting).
The bioengineered human skin equivalent is based on the use of
fibrin containing live fibroblasts as a dermal component (Meana
et al, 1998). Briefly, 3 mL of the fibrinogen (from cryoprecipitates)
were added to 12 mL of DMEM with 10% FCS containing 5  105
dermal fibroblasts and x500 IU of bovine aprotinin (Trasylol; Bayer,
West Haven, Connecticut). Immediately afterwards, 1 mL of 0.025
mM CaCl2 (Sigma, St Louis, Missouri) with 11 IU of bovine throm-
bin (Sigma) were added. Finally, the mixture was placed on a six-
well culture plate (Transwell; Costar, Cambridge, Massachusetts)
and allowed to solidify at 371C for 2 h. Untransduced control or
purified EGFPþ keratinocytes obtained by cell sorting were then
seeded and grown submerged up to keratinocyte confluence. Mice
were aseptically cleansed and grafted as previously described
elsewhere (Del Rio et al, 2002; Serrano et al, 2003; Llames et al,
2004). Briefly, full thickness 12 mm circular wounds were then
created on the dorsum of the mice. Untransduced control or
EGFP-bioengineered equivalents were placed orthotopically on the
wound. At 9–12 wk after transplantation, these stable engrafted
human skins were injured with 2 mm biopsy punches (STIEFEL
LAB, Madrid, Spain). At 1, 3, 5, 7, and 15 d post-wounding,
mice were euthanized by CO2 asphyxiation. Rectangular samples
of skin containing the wounds in the center were harvested and
fixed in 3.7% formaldehyde or 70% ethanol solution. After fixation
the skin biopsy was embedded in paraffin. Serial 4 mm cross sec-
tions were obtained. The whole sample was sectioned to deter-
mine the center of the wound and adequately monitor the healing
process.
Mice were housed for the duration of the experiment at the
CIEMAT Laboratory Animals Facility (Spanish registration number
28079-21 A) in pathogen-free conditions using individually venti-
lated type II cages (25 air changes per hour) and 10 KGy g-irra-
diated soft wood pellets as bedding. All handling was carried out
according to European and Spanish laws and regulations (Euro-
pean Convention 123, use and protection of Vertebrate Mammals
in experimentation and other scientific purposes. Spanish R.D.
223/88 and O.M. 13-10-89 of the Ministry of Agricultural, Food and
Fisheries, protection and use of animals in scientific research and
internal biosafety and bioethics guidelines).
Analysis of the wound-healing process: techniques of histol-
ogy and immunohistochemistry The wound-healing process,
either in untransduced control or EGFP-modified human skin, was
analyzed by histological and immunohistochemical techniques.
Paraffin sections were dewaxed by melting for 30–60 min at 601C,
cleared in xylene three times for 5 min, and re-hydrated in water
solutions containing decreasing percentages of ethanol. To deter-
mine tissue architecture, sections were stained with hematoxylin–
eosin (Gill 2 Haematoxylin and Eosin Y alcoholic; Thermo Sandon,
Cheshire, UK) following a standard procedure.
Two methods were used to determine the EGFP reporter gene
expression. Green fluorescence was readily visualized in the intact
xenograft in vivo using a fluorescence stereomicroscope under
blue light (Olympus, Olympus America, Melville, New York). For-
maldehyde fixed sections were used to perform immunohisto-
chemistry using specific polyclonal antibodies anti-EGFP (clone
A-11122, Molecular Probes, Eugene, Oregon) at a 1:200 dilution.
To describe the maturation program, formaldehyde (immuno-
peroxidase) or 70%-ethanol (immunofluorescence) fixed sections
were stained using specific antibodies against human epidermal
differentiation markers. The antibodies were used at final dilutions
of 1:600 for keratin K5 polyclonal (clone AF138: BabCO,
Richmond, California), of 1:50 for a-keratin 10 monoclonal (clone
AE2: ICN Biomedicals, Aurora, Ohio), of 1:3 for keratin 16 mono-
clonal (clone LL025 a gift from Dr Lane, Dundee University, UK),
1:100 for involucrin human-specific monoclonal antibody (clone
SY5: Sigma) and 1:2000 for loricrin polyclonal (clone AF-62:
BabCO, Ca). The presence of cell–cell adherent junctions of ep-
ithelial cells was monitored by the use of antibodies specific for e-
cadherin (clone 36, Transduction Lab, Lexington, Kentucky).
To determine the regeneration of the dermo-epidermal junction,
ethanol-fixed sections were used. In the case of immunofluores-
cence, sections were digested with 0.1% trypsin (ICN Biomedicals)
for 30 min. The sections were immunostained with specific anti-
bodies against two main components of the basement membrane:
laminin (clone LAM-89 Sigma) and collagen IV (clone PHM-
12þCIV 22: NeoMarkers, Fremont, California). Antibodies were
used at a final dilution of 1:200.
To evaluate dermal remodelling, formaldehyde fixed sections
were analyzed. Human fibroblasts were labelled using monoclonal
antibody to human vimentin (V9: BioGenex, San Romon, California)
at a final dilution of 1:50. The vimentin antibody does not react with
mice tissue. Therefore it provides additional proof of the human or-
igin of the regenerated dermis on the nude mice. Masson’s trichrome
(Acoustain Trichrome Stains-Masson; Sigma) was used as a marker
of collagen fibres following manufacturer’s recommendations.
In all cases, immunohistochemistry was performed using stand-
ard procedures. Immunoperoxidase staining was developed using
the Vectastain ABC kit (Vector, Burlingame, California). The max-
imum diameter in open wounds was selected by light microscopy
observation. The whole wound was sectioned and 1 of every 10
sections was stained with hematoxylin–eosin. In covered wounds,
the more immature area of the wound was determined by Mas-
son’s trichrome staining. The scab was also a useful landmark in
both cases.
Cell proliferation during wound healing Grafted mice were IP
injected with 20 mg per kg of BrdU 1 h before euthanasia. To
assess proliferation, immunohistochemistry using specific anti-
bodies against BrdU (Roche, Indianapolis) was performed. The
BrdU primary antibody was diluted 1:50. The number of BrdU-
positive basal nuclei in a unit length of 2.5 mm (containing the
center of the wound in wounded samples) was counted. A min-
imum of three animals was used for each time point.
rKGF treatment of wounds Twelve weeks post-grafting the re-
generated human skin was wounded using 2 mm biopsy-punches
as described above. Wounds were injected during three consec-
utive days with 1.5 mg of recombinant human KGF in 100 mL of PBS
(n¼ 3) or PBS alone (n¼ 3). The total volume was administered via
three separate injections around the wound margin. Samples were
harvested 3 d post-wounding, formalin fixed and histologically
processed. The percent of re-epithelialization across each wound
site was measured by light microscopy using a reticle to measure
the proportion of each wound that was covered by neoepidermis
in relation to the entire wound length (Staiano-Coico et al, 1993;
Pierce et al, 1994). The re-epithelialization percentage was calcu-
lated by the formula: 100  [(wound diameterepidermal gap)/
wound diameter]. The epidermal gap is the distance between op-
posite epithelial tongues.
Epidermal thickness was defined as the distance (in millimeters)
from the top of the granular layer to the bottom of the basal layer
(Staiano-Coico et al, 1993). Light microscopy using an ocular re-
ticle was used for these measurements. Approximately 30 individ-
ual measurements were made along the wound margin for each
histologic section and the mean thickness was evaluated.
Basal cell density was defined as the number of basal cells per
mm of the basement membrane (Andreadis et al, 2001). Finally, the
percentage of BrdU-positive basal nuclei was calculated by count-
ing 400 cells at the wound site.
Statistics A Student’s t test was applied to compare the means of
samples. Differences were considered statistically significant when
po0.05.
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Supplementary Material
The following material is available from http://www.blackwellpublishing.
com/products/journals/suppmat/JID/JID23473/JID23473sm.htm
Figure S1. Experimental design of the in vivo model of wound
healing in enhanced green ﬂuorescent protein (EGFP)-bioengi-
neered skin-humanized mice. (a, b) Procedure for the orthotopical
transplantation of the human bioengineered skin on the back of a 6-wk-
old nude mouse. (c) At 12 wk post-grafting, ﬁne wrinkles and clinical
signs of hyperkeratosis, both typical of native human skin, are present in
the regenerated EGFP-bioengineered human skin. (d) Microphotograph
of a 2 mm excisional wound performed on the regenerated EGFP-bio-
engineered human skin. (e) Fluorescent epiillumination shows the
EGFP-positive area corresponding to the wounded graft in panel d. Hu-
man and mouse skin boundaries are outlined by a dashed line in d and
e. Note the negligible mice skin autoﬂuorescence in the area surround-
ing the graft.
Figure S2. Phenotypic characterization of unwounded enhanced
green ﬂuorescent protein (EGFP)-bioengineered skin-humanized
mice. (a) Immunoperoxidase staining of human involucrin at the junction
of regenerated human skin and murine host denoting the human origin
of the regenerated epidermis. (b) Immunoperoxidase staining of human
vimentin at the junction of regenerated human skin and murine host. (c)
Masson trichrome staining showing a collagen-rich dermis with indistin-
guishable boundaries between host and the regenerated skin. (d) EGFP
immunoperoxidase staining of the transgenic regenerated human skin.
Figure S3. Human origin of the components involved in the wound
repair in enhanced green ﬂuorescent protein (EGFP)-bioengi-
neered skin-humanized mice. Composite pictures are shown in all
panels. (a) Re-epithelialization of a 3-d wound by an EGFP-positive
epithelium (EGFP immunoperoxidase staining). (b) EGFP-positive
neoepidermis completely re-epithelialized a wound after 7 d (EGFP
immunoperoxidase staining). (c) Immunoperoxidase staining of human
involucrin in a consecutive section to that shown in panel a. (d)
Immunoperoxidase staining of human involucrin of a 15-day wound. (e)
Immunoperoxidase staining of human vimentin of a 3-d wound. (f)
Immunoperoxidase staining of human vimentin in a consecutive section
to that shown in panel b (7-d wound).
Figure S4. Dermal matrix regeneration during wound repair in
enhanced green ﬂuorescent protein (EGFP)-bioengineered skin-
humanized mice. Collagen deposition analyzed by Masson’s
Trichrome staining (blue staining). (a) Composite picture showing a
panoramic view of a 1-d wound. (b) Composite picture showing a pan-
oramic view of a 7-d wound. (c) Composite picture showing a panoramic
view of a 15-d wound. (d) Close up view of the center of the wound
shown in panel a (ﬁbrin clot). (e) Close up view of the center of the
wound shown in panel b (granulation tissue). (f ) Close up view of the
center of the wound shown in panel c (immature collagenous dermis).
(g) Close up view of the wound margin shown in panel c (more mature
collagenous dermis).
Figure S5. Dermo-epidermal junction regeneration during wound
repair in enhanced green ﬂuorescent protein (EGFP)-bioengi-
neered skin-humanized mice. (a) Laminin immunoperoxidase stain-
ing of a unwounded skin-humanized mouse 12 wk post-grafting. (b)
Immunoﬂuorescence staining of collagen IV (red) superposed on the
DAPI nuclear staining of the cells (blue) at 3 d post-wounding. Dotted
lines outlines the migratory tongue. Arrow heads indicate the basement
membrane beneath the epidermis. (c) Laminin immunoperoxidase stain-
ing of a 7-d wound. Laminin labelling decreases in areas closer to the
wound center (arrows). (d) Immunoﬂuorescence staining of collagen IV
(red) superposed on the DAPI nuclear staining of the cells (blue) at 15d
post-wounding. Collagen deposition was restored in the center of the
wound. Collagen staining was also associated to the basement mem-
brane blood vessels in the dermis.
Figure S6. Proliferative activity in response to wound in enhanced
green ﬂuorescent protein (EGFP)-bioengineered skin-humanized
mice. Immunoperoxidase staining of bromodeoxyuridine (BrdU). (a)
BrdU-positive nuclei in the epidermis and the dermis of unwounded skin
(arrows). (b) BrdU-positive nuclei in the tail of a 3-d migratory epidermal
tongue and in the granulation tissue. (c) BrdU-positive nuclei in the ep-
idermis and the dermis of a 15-d wound (center). (d) Percentage of
BrdU-positive nuclei was calculated for the neoepidermis at different
time points post-wounding and for the unwounded epidermis (non trans-
duced and EGF-expressing) (e) Percentage of BrdU-positive nuclei was
calculated for each region of the EGFP-expressing migratory epidermal
tongue. Results are expressed as mean  SD. po0.05 and po0.01
compared to unwounded epidermis.
Table S1.
DOI: 10.1111/j.0022-202X.2004.23473.x
Manuscript received May 19, 2004; revised May 19, 2004; accepted for
publication June 28, 2004
Address correspondence to: Marcela Del Rio, CIEMAT, Avenida
Complutense 22 Edificio 7, 28040 Madrid, Spain. Email: marcela.delrio
@ciemat.es
References
Andreadis ST, Hamoen KE, Yarmush ML, Morgan JR: Keratinocyte growth factor
induces hyperproliferation and delays differentiation in a skin equivalent
model system. FASEB J 15:898–906, 2001
Bereiter-Hahn J: Epidermal cell migration and wound repair. In: Bereiter-Hahn J,
Matoltsy AG, Richards KS (eds). Biology of the Integuments. Vol. 2: Ver-
tebrates. Berlin: Springer-Verlag, 1986; p 443–471
Biddle D, Spandau DF: Expression of vimentin in cultured human keratinocytes is
associated with cell–extracellular matrix junctions. Arch Dermatol Res
288:621–624, 1996
Boyer B, Valles AM, Edme N: Induction and regulation of epithelial–mesenchymal
transitions. Biochem Pharmacol 60:1091–1099, 2000
Buisson AC, Gilles C, Polette M, Zahm JM, Birembaut P, Tournier JM: Wound
repair-induced expression of a stromelysins is associated with the ac-
quisition of a mesenchymal phenotype in human respiratory epithelial
cells. Lab Invest 74:658–669, 1996
Burgeson RE, Christiano AM: The dermal–epidermal junction. Curr Opin Cell Biol
9:651–658, 1997
Cavani A, Zambruno G, Marconi A, Manca V, Marchetti M, Giannetti A: Distinctive
integrin expression in the newly forming epidermis during wound healing
in humans. J Invest Dermatol 101:600–604, 1993
Clark RAF: The molecular and cellular biology of wound repair. New York and
London: Plenum Press, 1996
Croft CB, Tarin D: Ultrastructural studies of wound healing in mouse skin. I.
Epithelial behaviour. J Anat 106:63–77, 1970
Del Rio M, Larcher F, Meana A, Segovia J, Alvarez A, Jorcano J: Nonviral transfer
of genes to pig primary keratinocytes. Induction of angiogenesis by
composite grafts of modified keratinocytes overexpressing VEGF driven
by a keratin promoter. Gene Ther 6:1734–1741, 1999
Del Rio M, Larcher F, Serrano F, et al: A preclinical model for the analysis of ge-
netically modified human skin in vivo. Hum Gene Ther 13:959–968, 2002
Demarchez M, Hartmann DJ, Herbage D, Ville G, Prunieras M: Wound healing of
human skin transplanted onto the nude mouse. II. An immunohistological
and ultrastructural study of the epidermal basement membrane zone recon-
struction and connective tissue reorganization. Dev Biol 121:119–129, 1987
Demarchez M, Sengel P, Prunieras M: Wound healing of human skin transplanted
onto the nude mouse. I. An immunohistological study of the re-epithe-
lialization process. Dev Biol 113:90–96, 1986
Eming SA, Lee J, Snow RG, Tompkins RG, Yarmush ML, Morgan JR: Genetically
modified human epidermis overexpressing PDGF-A directs the develop-
ment of a cellular and vascular connective tissue stroma when trans-
planted to athymic mice—Implications for the use of genetically modified
keratinocytes to modulate dermal regeneration. J Invest Dermatol 105:
756–763, 1995
Eming SA, Medalie DA, Tompkins RG, Yarmush ML, Morgan JR: Genetically
modified human keratinocytes overexpressing PDGF-A enhance the per-
formance of a composite skin graft. Hum Gene Ther 9:529–539, 1998
Falanga V, Isaacs C, Paquette D, et al: Wounding of bioengineered skin: Cellular
and molecular aspects after injury. J Invest Dermatol 119:653–660, 2002
Fuchs E: Epidermal differentiation: The bare essentials. J Cell Biol 111:2807–2814,
1990
Garlick JA, Katz AB, Fenjves ES, Taichman LB: Retrovirus-mediated transduction
of cultured epidermal keratinocytes. J Invest Dermatol 97:824–829, 1991
Garlick JA, Taichman LB: Fate of human keratinocytes during re-epithelialization
in an organotypic culture model. Lab Invest 70:916–924, 1994
1190 ESCA´MEZ ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Gibbins JR, Manthey A, Tazawa YM, Scott B, Bloch-Zupan A, Hunter N: Midline
fusion in the formation of the secondary palate anticipated by upregu-
lation of keratin K5/6 and localized expression of vimentin mRNA in me-
dial edge epithelium. Int J Dev Biol 43:237–244, 1999
Gilles C, Polette M, Zahm JM, Tournier JM, Volders L, Foidart JM, Birembaut P:
Vimentin contributes to human mammary epithelial cell migration. J Cell
Sci 112:4615–4325, 1999
Hamoen KE, Morgan JR: Transient hyperproliferation of a transgenic human epidermis
expressing hepatocyte growth factor. Cell Transplant 11:385–395, 2002
Kiemer AK, Takeuchi K, Quinlan MP: Identification of genes involved in epithelial-
mesenchymal transition and tumor progression. Oncogene 20:6679–6688,
2001
Krawczyk WS: A pattern of epidermal cell migration during wound healing. J Cell
Biol 49:247–263, 1971
Laplante AF, Germain L, Auger FA, Moulin V: Mechanisms of wound re-epithe-
lialization: Hints from a tissue-engineered reconstructed skin to long-
standing questions. FASEB J 15:2377–2389, 2001
Larcher F, Del Rio M, Serrano F, et al: A cutaneous gene therapy approach to
human leptin deficiencies: Correction of the murine ob/ob phenotype
using leptin-targeted keratinocyte grafts. Faseb J. 15:1529–1538, 2001
Larjava H, Salo T, Haapasalmi K, Kramer RH, Heino J: Expression of integrins and
basement membrane components by wound keratinocytes. J Clin Invest
92:1425–1435, 1993
Leigh IM, Navsaria H, Purkis PE, McKay IA, Bowden PE, Riddle PN: Keratins (K16
and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo
and in vitro. Br J Dermatol 133:501–511, 1995
Llames SG, Del Rio M, Larcher F, et al: Human plasma as a dermal scaffold for
the generation of a completely autologous bioengineered skin. Trans-
plantation 77:350–355, 2004
Mansbridge JN, Knapp AM: Changes in keratinocyte maturation during wound
healing. J Invest Dermatol 89:253–263, 1987
Martin P: Wound healing-aiming for perfect skin regeneration. Science 276:
75–81, 1997
Matoltsy AG, Viziam CB: Further observations on epithelialization of small
wounds: An autoradiographic study of incorporation and distribution of
3H-thymidine in the epithelium covering skin wounds. J Invest Dermatol
55:20–25, 1970
Meana A, Iglesias J, Del Rio M, et al: Large surface of cultured human epithelium
obtained on a dermal matrix based on live fibroblast-containing fibrin
gels. Burns 24:621–630, 1998
Odland G, Ross R: Human wound repair. I. Epidermal regeneration. J Cell Biol
39:135–151, 1968
Ortonne JP, Loning T, Schmitt D, Thivolet J: Immunomorphological and ultra-
structural aspects of keratinocyte migration in epidermal wound healing.
Virchows Arch A Pathol Anat Histol 392:217–230, 1981
Paladini RD, Takahash K, Bravo NS, Coulombe PA: Onset of re-epithelialization
after skin injury correlates with a reorganization of keratin filaments
in wound edge keratinocytes: Defining a potential role for keratin 16. J Cell
Biol 132:381–397, 1996
Pellegrini G, Ranno R, Stracuzzi G, et al: The control of epidermal stem cells
(holoclones) in the treatment of massive full-thickness burns with auto-
logous keratinocytes cultured on fibrin. Transplantation 68:868–879,
1999
Pierce GF, Yanagihara D, Klopchin K, Danilenki DM, Hsu E, Kenney WC, Morris
CF: Stimulation of all epithelial elements during skin regeneration by ker-
atinocyte growth factor. J Exp Med 179:831–840, 1994
Rheinwald JG, Green H: Serial cultivation of strains of human epidermal kera-
tinocytes: The formation of keratinizing colonies from single cells. Cell
6:331–343, 1975
Robbins PB, Lin Q, Goodnough JB, Tian H, Chen X, Khavari PA: In vivo resto-
ration of laminin 5 beta 3 expression and function in junctional
epidermolysis bullosa. Proc Natl Acad Sci USA 98:5193–5198, 2001
Ronfard V, Rives JM, Neveux Y, Carsin H, Barrandon Y: Long-term regeneration of
human epidermis on third degree burns transplanted with autologous cul-
tured epithelium grown on a fibrin matrix. Transplantation 70:1588–1598,
2000
Ross R, Odland G: Human wound repair. II. Inflammatory cells, epithelial–me-
senchymal interrelations, and fibrogenesis. J Cell Biol 39:152–168, 1968
Rossio-Pasquier P, Casanova D, Jomard A, Demarchez M: Wound healing of
human skin transplanted onto the nude mouse after a superficial excisional
injury: Human dermal reconstruction is achieved in several steps by
two different fibroblast subpopulations. Arch Dermatol Res 291:591–599,
1999
Scheid A, Meuli M, Gassmann M, Wenger RH: Genetically modified mouse
models in studies on cutaneous wound healing. Exp Physiol 85:687–704,
2000
Serrano F, Del Rio M, Larcher F, et al: A comparison of targeting performance
of oncoretroviral versus lentiviral vectors on human keratinocytes. Hum
Gene Ther 14:1579–1585, 2003
Singer AJ, Clark RAF: Cutaneous wound healing. N Engl J Med 341:738–746, 1999
Spirito F, Meneguzzi G, Danos O, Mezzina M: Cutaneous gene transfer and ther-
apy: The present and the future. J Gene Med 3:21–31, 2001
Staiano-Coico L, Krueger JG, Rubin JS, et al: Human keratinocyte growth factor
effects in a porcine model of epidermal wound healing. J Exp Med 178:
865–878, 1993
Steinert PM, Roop DR: Molecular and cellular biology of intermediate filaments.
Annu Rev Biochem 57:593–625, 1988
SundarRaj NJ, Rizzo D, Anderson SC, Gesiotto JP: Expression of vimentin by
rabbit corneal epithelial cells during wound repair. Cell Tissue Res 267:
347–356, 1992
Supp DM, Bell SM, Morgan JR, Boyce ST: Genetic modification of cultured
skin substitutes by transduction of human keratinocytes and fibroblasts
with platelet-derived growth factor-A. Wound Repair Regen 8:26–35,
2000a
Supp DM, Boyce ST: Overexpression of vascular endothelial growth factor
accelerates early vascularization and improves healing of genetically
modified cultured skin substitutes. J Burn Care Rehabil 23:10–20,
2002
Supp DM, Supp AP, Bell SM, Boyce ST: Enhanced vascularization of cultured skin
substitutes genetically modified to overexpress vascular endothelial
growth factor. J Invest Dermatol 114:5–13, 2000b
Tarin D, Croft CB: Ultrastructural studies of wound healing in mouse skin. II.
Dermo-epidermal interrelationships. J Anat 106:79–91, 1970
Weiss RA, Eichner R, Sun TT: Monoclonal antibody analysis of keratin expression
in epidermal diseases: A 48- and 56-kdalton keratin as molecular markers
for hyperproliferative keratinocytes. J Cell Biol 98:1397–1406, 1984
Werner S: Keratinocyte growth factor: A unique player in epithelial repair proc-
esses. Cytokine Growth Factor Rev 9:153–165, 1998
Werner S, Breeden M, Hubner G, Greenhalgh DG, Longaker MT: Induction of
keratinocyte growth factor expression is reduced and delayed during
wound healing in the genetically diabetic mouse. J Invest Dermatol 103:
469–473, 1994
Werner S, Grose R: Regulation of wound healing by growth factors and
cytokines. Physiol Rev 83:835–870, 2003
Winstanley EW: The epithelial reaction in the healing of excised cutaneous
wounds in the dog. J Comp Pathol 85:61–75, 1975a
Winstanley EW: The rate of mitotic division in regenerating epithelium in the dog.
Res Vet Sci 18:144–148, 1975b
WOUND HEALING IN GENE-TRANSFERRED HUMAN SKIN 1191123 : 6 DECEMBER 2004
